Carlos O Esquivel

7PUBLICATIONS
32CO-AUTHORS
Haematological tumoursCardiology (incl. cardiovascular diseases)Access to justiceLegal institutions (incl. courts and justice systems)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 04, 2026
Interleukin-37 Enhances Liver NK Cell Cytotoxicity and Improves Recurrence-Free Survival in Hepatocellular Carcinoma Patients.

|Dec 16, 2024
Hepatitis C-positive grafts for hepatitis C-negative recipients in liver transplantation: Buried treasure or depleting resource?

Toshihiro Nakayama, David T Krist, Miho Akabane

|Oct 16, 2024
Does the introduction of the acuity circle policy change split liver transplantation practice?

Toshihiro Nakayama, Miho Akabane, Yuki Imaoka

|May 10, 2024
An updated analysis of retransplantation following living donor liver transplantation in the United States: Insights from the latest UNOS database.

Miho Akabane, Yuki Imaoka, Carlos O Esquivel

|Apr 16, 2024
Enhancing the usability of older DCD donors through strategic approaches in liver transplantation in the United States.

Miho Akabane, Marc L Melcher, Carlos O Esquivel

|Jan 04, 2024
Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma.

Daniel Q Huang, Joseph K Hoang, Rubayet Kamal

Pageof 2

Frequent Collaborators

6 joint publications

Kazunari Sasaki

6 joint publications

Yuki Imaoka

6 joint publications

Miho Akabane

4 joint publications

Marc L Melcher